Patients with NSCLC may display a low ratio of p.T790M vs. activating EGFR mutations in plasma at disease progression: implications for personalised treatment.
scientific article published on 15 September 2017
Author/s
author: Marzia Del Re, Paola Bordi, Iacopo Petrini, Lorenzo Belluomini, Alfredo Falcone, Marcello Tiseo, Romano Danesi, Ron van Schaik, Enrico Vasile, Eleonora Rofi, Giuliana Restante, Riccardo Morganti
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.